Dr. Gurumurthy Hiremath completed his pediatric cardiology training and a 4th year of interventional training at the University of California, San Francisco. He is currently the director of the congenital cardiac catheterization laboratories and cardiopulmonary exercise testing at the University of Minnesota’s Masonic Children’s Hospital and the associate division director for pediatric cardiology. His clinic interests include pulmonary artery stenting, transcatheter pulmonary valve placements, device closures of intracardiac defects, interventions in adults with congenital heart disease, and hybrid interventional procedures in partnership with cardiac surgeons.
Dr. Hiremath's research interests are focused on improving our understanding of the physiological effects of transcatheter interventions. He completed a prospective multi-center clinical study looking at the physiologic effects of successful treatment of unilateral pulmonary artery stenosis. He is actively involved in the use of intracardiac pressure-volume loops to understand the physiological effects of transcatheter interventions. He has several active research grants and has authored several publications and book chapters.
Dr. Hiremath is an active member of the interventional cardiology societies, with active roles in the SCAI’s Congenital Heart Disease Council, the Pediatric Interventional Cardiology Early Career Society (PICES), and the Pediatric Interventional Cardiology CPT coding group. He served as the Research Vice President of PICES (Pediatric Interventional Cardiology Early Career Society) from 2018–2020, where he planned, coordinated, and led several multicenter research projects under its auspices. He is actively involved with industry in developing new intracardiac devices and participates in several national device trials and registries. He has received several awards, including the University of Minnesota's 'Innovation in Clinical Practice Award’ for developing innovative treatments and industry partnerships to improve patient care.
